Prophylactic Peripheral Blood Stem Cell Collection in Patients with Extensive Bone-Marrow Infiltration of Neuroendocrine Tumours Prior to Peptide Receptor Radionuclide Therapy with ¹⁷⁷Lu-DOTATATE

• Main Authors: Amir Sabet (Author), Nicolai Mader (Author), Jörg Thomas Bittenbring (Author), Fadi Khreish (Author), Frank Grünwald (Author), Hans Jürgen Biersack (Author), Samer Ezziddin (Author)
• Format: Book
• Published: MDPI AG, 2021-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Peptide receptor radionuclide therapy (PRRT) of metastatic neuroendocrine tumors (NET) can be successfully repeated but may eventually be dose-limited. Since ¹⁷⁷Lu-DOTATATE dose limitation may come from hematological rather than renal function, hematological peripheral blood s...